← Back to Search

Digital Therapeutic

HPDT-DA-013 for Generalized Anxiety Disorder

N/A
Waitlist Available
Led By Roger Vilardaga, Ph.D.
Research Sponsored by Happify Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, average of 14 months
Awards & highlights

Study Summary

This trial will test a digital therapeutic for people with Major Depressive Disorder or Generalized Anxiety Disorder.

Eligible Conditions
  • Depression
  • Generalized Anxiety Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, average of 14 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, average of 14 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Generalized Anxiety Disorder-7 (GAD-7)
Patient Health Questionnaire-9 (PHQ-9)
Secondary outcome measures
GAD-7
PHQ-9

Trial Design

1Treatment groups
Experimental Treatment
Group I: Digital therapeuticExperimental Treatment1 Intervention
Use HPDT-DA-013 digital therapeutic for a period of 8-10 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HPDT-DA-013
2021
N/A
~370

Find a Location

Who is running the clinical trial?

Happify Inc.Lead Sponsor
6 Previous Clinical Trials
21,257 Total Patients Enrolled
Roger Vilardaga, Ph.D.Principal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are involved in this scientific investigation?

"Affirmative. Data accessible on clinicaltrials.gov indicates that this medical study, which first appeared on 8/9/2021, is currently recruiting patients. 750 participants need to be enlisted across a single location."

Answered by AI

Are there any available vacancies for participants in this trial?

"According to the information available on clinicaltrials.gov, this medical trial is currently in a recruitment phase after being initially posted on August 9th 2021 and subsequently updated as recently as October 21st 2022."

Answered by AI

Who else is applying?

What state do they live in?
Nebraska
New Jersey
Other
New York
How old are they?
65+
18 - 65
What site did they apply to?
Happify Health (Remote)
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria

How responsive is this trial?

Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)
2021. "Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05016050.
~100 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top